Evaluation of Antibacterial Drugs Using Silkworms Infected by Cutibacterium acnes

Yasuhiko Matsumoto1, Yuki Tateyama1, Takashi Sugita1

  • 1Department of Microbiology, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose 204-8588, Tokyo, Japan.

Insects
|August 6, 2021
PubMed

Insights

A new silkworm model effectively mimics Cutibacterium acnes systemic infections. This model helps study bacterial toxicity and test antimicrobial drug efficacy in vivo.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Animal Models

Background:

  • Cutibacterium acnes (C. acnes) causes inflammatory skin and systemic infections.
  • Treating systemic C. acnes infections is challenging, necessitating new experimental models.
  • A robust model is crucial for understanding infection mechanisms and developing therapies.

Purpose of the Study:

  • To establish and validate a silkworm infection model for C. acnes.
  • To assess the model's utility in evaluating C. acnes host toxicity.
  • To determine the model's effectiveness in screening antimicrobial drugs.

Main Methods:

  • Silkworms were infected with live C. acnes and reared at 37°C.
  • The lethal dose 50 (LD50) was determined.
  • Bacterial load in hemolymph and fat body was quantified.
  • Silkworms were treated with antibiotics (tetracycline, clindamycin).

Main Results:

  • Silkworms infected with C. acnes at 37°C exhibited mortality.
  • LD50 was established under these conditions.
  • C. acnes viable cell counts increased in silkworm hemolymph and fat body.
  • Heat-killed C. acnes did not cause mortality.
  • Antibiotic treatment significantly prolonged silkworm survival.

Conclusions:

  • The silkworm model accurately reflects C. acnes systemic infection.
  • This model is suitable for evaluating C. acnes-induced host toxicity.
  • The silkworm model demonstrates efficacy for in vivo antimicrobial drug screening.

Related Concept Videos